1. Clinical Benefits of Azilsartan Beyond Blood Pressure Lowering?

   • Takashi Kajiya

   EDITORIAL 24 June 2014 Pages: 293 - 294

2. Capsaicin-Induced Cardioprotection. Is Hypothermia or the Salvage Kinase Pathway Involved?

   • Joan Dow
   • Boris Z. Simkhovich
   • Robert A. Kloner

   ORIGINAL ARTICLE 18 May 2014 Pages: 295 - 301

   

3. MiR-132 Inhibits Expression of SIRT1 and Induces Pro-inflammatory Processes of Vascular Endothelial Inflammation through Blockade of the SREBP-1c Metabolic Pathway

   • Liwei Zhang
   • Dangsheng Huang
   • Luyue Gai

   ORIGINAL ARTICLE 13 June 2014 Pages: 303 - 311

   

4. Azilsartan Decreases Renal and Cardiovascular Injury in the Spontaneously Hypertensive Obese Rat

   • Md. Abdul Hye Khan
   • Jan Neckář
   • John D. Imig

   ORIGINAL ARTICLE 20 May 2014 Pages: 313 - 322

   

5. Laboratory Aspirin Resistance Reversibility in Diabetic Patients: a Pilot Study Using Different Pharmaceutical Formulations

   • Roberto Grimaldi
   • Marta Bisi
   • Fiorenzo Gaita

   ORIGINAL ARTICLE 02 July 2014 Pages: 323 - 329

   

6. Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors: New among Antidiabetic Drugs

   • L. H. Opie

   REVIEW ARTICLE 14 May 2014 Pages: 331 - 334

   

7. Renin-Angiotensin System Phenotyping as a Guidance Toward Personalized Medicine for ACE Inhibitors: can the Response to ACE Inhibition be Predicted on the Basis of Plasma Renin or ACE?

   • Joyce E.M. Schilders
   • Haiyan Wu
   • A.H. Jan Danser

   ORIGINAL ARTICLE 24 June 2014 Pages: 335 - 345

   

8. Thioredoxin-Interacting Protein: Pathophysiology and Emerging Pharmacotherapeutics in Cardiovascular Disease and Diabetes

   • Cher-Rin Chong
   • Wai Ping A. Chan
   • John D. Horowitz

   REVIEW ARTICLE 05 August 2014 Pages: 347 - 360

   

9. Lipid-lowering Therapies, Glucose Control and Incident Diabetes: Evidence, Mechanisms and Clinical Implications

   • Barak Zafrir
   • Mohit Jain

   ORIGINAL ARTICLE 21 June 2014 Pages: 361 - 377

   

10. Biodegradable Polymer Drug-Eluting Stents Versus Second-Generation Drug-Eluting Stents for Patients With Coronary Artery Disease: An Update Meta-Analysis

    • Yanyu Wang
    • Pingshuan Dong
    • Xiyan Shang

    ORIGINAL ARTICLE 20 May 2014 Pages: 379 - 385

    

11. Histogram and Vertical Bar diagram: Often Misapprehended Concept

    • Mageshwaran Lakshmanan

    LETTER TO THE EDITOR Open access 13 June 2014 Pages: 387 - 387

12. Answer to: “Histogram and Vertical Bar Diagram: Often Misapprehended Concept” by M. Lakshmanan

    • Jie Du

    LETTER TO THE EDITOR 13 June 2014 Pages: 389 - 389

13. NLRP3, a Potential Therapeutic Target for Type 2 Diabetes?

    • Shan-Shan Liu
    • Ye Ding
    • Ji-Quan Lou

    LETTER TO THE EDITOR 28 May 2014 Pages: 391 - 392